Table: Shin Nippon Biomedical -Q1 group results

Shin Nippon Biomedical Laboratories

06/08/2024 01:00

Aug 6 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             5.55                5.80             29.84    
                 (-4.4 pct)          (+43.5 pct)      (+12.8 pct) 
  Operating     loss 145 mln            1.23              2.35    
                                     (+71.9 pct)      (-43.5 pct) 
  Recurring        342 mln              1.88              5.35    
                 (-81.8 pct)         (-32.3 pct)      (-23.8 pct) 
  Net              122 mln              1.37              3.92    
                 (-91.1 pct)         (-29.4 pct)      (-29.1 pct) 
  EPS             2.93 yen            32.98 yen        94.15 yen  
  Ann Div                             50.00 yen        50.00 yen  
  -Q2 div                             20.00 yen        20.00 yen  
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T